Videos

Educated Patient® Metastatic Breast Cancer Summit Integrating Alternative Medicine Presentation: June 11, 2022

June 29th 2022

Watch Dr. Anna Bausum, Winship Cancer Institute at Emroy University, discuss alternative medicine, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Future Perspectives in Renal Cell Carcinoma (RCC)

June 29th 2022

Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.

Educated Patient® Metastatic Breast Cancer Summit Supportive Care Presentation: June 11, 2022

June 28th 2022

Watch Dr. Kimberly Curseen, from Winship Cancer Institute of Emory University, discuss supportive care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Updates in Disease Management Panel: June 11, 2022

June 27th 2022

Watch Dr. Suchita Pakkala, Dr. Jane Meisel, Dr. Keerthi Gogineni and Kelly Shanahan discuss updates in disease management during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Metastatic Triple-Negative Presentation: June 11, 2022

June 26th 2022

Watch Dr. Keerthi Gogineni, from Emory University School of Medicine, discuss the management of triple-negative disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Estrogen Receptor-Positive Presentation: June 11, 2022

June 24th 2022

Watch Dr. Suchita Pakkala, from Emory University School of Medicine, discuss estrogen receptor-positive disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

June 22nd 2022

Dr Thomas Hutson shares his experience with tivozanib in his practice and ways to counsel patients regarding treatment options in the third-line setting.

Tivozanib: Adverse Event Profile and How Toxicities are Managed

June 22nd 2022

Dr Thomas Hutson reviews the adverse event profile of tivozanib and provides advice to community oncologists on how to best manage these toxicities.

Educated Patient® Prostate Cancer Summit Looking Ahead Panel: May 21, 2022

June 17th 2022

Watch Dr. Jeremie Calais, Dr. Tian Zhang, Dr. Landon C. Brown and Jim Rosenfield answer questions about novel agents and strategies during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Approaches to Hormone Therapy Presentation: May 21, 2022

June 16th 2022

Watch Dr. Landon C. Brown, from Atrium Health Levine Cancer Institute, discuss approaches to hormone therapy, during the CURE Educated Patient Prostate Cancer Summit.

Clinical Implications of the TIVO-3 Trial

June 15th 2022

Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.

Treatment Options for Patients with Renal Cell Carcinoma (RCC)

June 15th 2022

An overview of the treatment options available for patients with renal cell carcinoma (RCC).

Educated Patient® Prostate Cancer Summit Novel Agents Presentation: May 21, 2022

June 15th 2022

Watch Dr. Tian Zhang, from UT Southwestern Medical Center, discuss novel agents, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Novel Imaging Strategies Presentation: May 21, 2022

June 14th 2022

Watch Dr. Jeremie Calais, from UCLA, discuss novel imaging strategies, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Genetics & Genomics Panel: May 21, 2022

June 13th 2022

Watch Dr. Veda N. Giri, Dr. Umang Swami and Sue Friedman answer questions about genetics and genomics during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Genomics Presentation: May 21, 2022

June 12th 2022

Watch Dr. Umang Swami, from Huntsman Cancer Institute, discuss genomic changes and PARP inhibitors, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Genetic Testing Presentation: May 21, 2022

June 11th 2022

Watch Dr. Veda N. Giri, from Sidney Kimmel Cancer Center at Thomas Jefferson University, discuss genetic testing and who should get it, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Treatment in Localized Disease Panel: May 21, 2022

June 10th 2022

Watch Dr. Ganesh Raj, Dr. Andrew Z. Wang, and Bruce Williams, discuss treatment for localized disease, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Approaches to Radiation Presentation: May 21, 2022

June 9th 2022

Watch Dr. Andrew Z. Wang, from UT Southwestern Medical Center, discuss approaches to radiation for local disease, during the CURE Educated Patient Prostate Cancer Summit.

Educated Patient® Prostate Cancer Summit Overview of Surgery Presentation: May 21, 2022

June 8th 2022

Watch Dr. Ganesh V. Raj, from UT Southwestern Medical Center, discuss surgery for localized disease, during the CURE Educated Patient Prostate Cancer Summit.

Overview of Metastatic Castration Resistant Prostate Cancer (mCRPC)

June 1st 2022

An overview of metastatic castration-resistant prostate cancer (mCRPC) and the role of PSMA in mCRPC.

Discussing the Importance of Genetic Counseling in Women’s Cancer

May 27th 2022

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about genetics in women’s cancer.

Addressing Barriers to Care, Improving Access in Women’s Cancers

May 27th 2022

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about access to care in women’s cancer.

Transitioning from Active Care to Survivorship in Women’s Cancer

May 27th 2022

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about survivorship in women’s cancer.

Expert Offers Advice on Maintaining a Healthy Lifestyle Before, During and After Cancer Treatment

May 27th 2022

As part of its Speaking Out video series, CURE spoke with Dr. Navya Nair, on behalf of the Foundation for Women’s Cancer, about maintaining a healthy lifestyle in women’s cancer.

Unmet Needs in the Management of EGFR Exon 20–Positive NSCLC

May 27th 2022

Before closing out their discussion on treatment for EGFR Exon 20–Positive NSCLC, experts discuss prominent unmet needs in this setting.

The Integration of Complementary Cancer Care May ‘Accelerate’ in Coming Years, Says Patrick Dempsey

May 24th 2022

Actor and cancer advocate Patrick Dempsey predicts that more focus will be put on complementary cancer care, such as nutrition and environmental factors, over the next several years.

Myelofibrosis Symptom Management Is ‘Incredibly Important’ to Preserve Quality of Life

May 24th 2022

Myelofibrosis may cause major impairments to a patient’s quality of life, which is why it is pertinent that patients work with their clinicians to address these side effects.

Educated Patient® MPN Summit Disease Approaches Panel: May 7, 2022

May 24th 2022

Watch Dr. Jamile Shammo and Dr. Srdan Vestovsek answer questions about disease approaches during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Novel Agents & Clinical Trials in Myelofibrosis Presentation: May 7, 2022

May 23rd 2022

Watch Dr. Srdan Vestovsek, from The University of Texas MD Anderson Cancer Center, discuss novel agents and clinical trials in myelofibrosis, during the CURE Educated Patient MPN Summit.